4//SEC Filing
Lorrain Daniel S. 4
Accession 0001437749-24-035887
CIK 0001855175other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 5:07 PM ET
Size
7.4 KB
Accession
0001437749-24-035887
Insider Transaction Report
Form 4
Lorrain Daniel S.
Chief Scientific Officer
Transactions
- Sale
Class A Common Stock
2024-11-18$16.37/sh−6,091$99,733→ 169,671 total - Sale
Class A Common Stock
2024-11-18$17.05/sh−99$1,688→ 169,572 total
Holdings
- 3,898(indirect: By Spouse)
Class A Common Stock
Footnotes (3)
- [F1]This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on August 19, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.03 to $17.02, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- [F3]Includes 325 shares purchased through Issuer's Employee Stock Purchase Plan.
Documents
Issuer
Contineum Therapeutics, Inc.
CIK 0001855175
Entity typeother
Related Parties
1- filerCIK 0001861550
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 5:07 PM ET
- Size
- 7.4 KB